The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases

2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases

February 16, 2016 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Image Credit: Petr Vaclavek/shutterstock.com

Image Credit: Petr Vaclavek/shutterstock.com

SAN FRANCISCO—Metabolomics could one day be a treasure map of information about inflammation in rheumatic disease. There are many metabolic pathways to pursue for clues on how to reverse this damaging process. “All of these signaling pathways are interrelated and affect each other,” said Douglas J. Veale, MD, director of translational research at Dublin Academic Medical Centre and a consulting rheumatologist at St. Vincent’s Hospital in Dublin, Ireland. “No one, single signaling pathway is responsible for inflammation.”

You Might Also Like
  • 2015 ACR/ARHP Annual Meeting: How to Identify, Manage Metabolic Myopathies & Their Mimics
  • 2015 ACR/ARHP Annual Meeting: Genetically Complex Auto-Inflammatory Diseases
  • 2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response
Explore This Issue
February 2016
Also By This Author
  • The ACR Introduces a New Reproductive Health Guideline

Dr. Veale was one of a panel of speakers who delved into metabolomics’ role in inflammatory arthritis at the 2015 ACR/ARHP Annual Meeting on Nov. 7, 2015. Topics included glycolysis, hypoxia and metabolomics’ role in both acute and chronic inflammation. Researchers are keen to learn more about how manipulating cell metabolism may, in the future, facilitate the development of more effective therapies.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Glucose Metabolism

“Metabolic reprogramming of cells is essential to support immune function,” explained Jeffrey Rathmell, PhD, associate professor of pharmacology, cancer biology, and immunology at the Duke University School of Medicine in Durham, N.C. Many therapies for autoimmune disorders are metabolic inhibitors, he said.

One important metabolic pathway is glycolysis, Dr. Rathmell said. T lymphocytes that drive autoimmunity produce energy through metabolism and require glucose as fuel.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Why do cells go through the change from an oxidative state then to aerobic glycolysis?” Cancer cells especially go through aerobic glycolysis, a process that includes increased uptake of glucose. “And it’s not just glucose. T cell activation also broadly reshapes the metabolome,” Dr. Rathmell said. T cell stimulation strongly upregulates this glucose uptake.

It’s still unclear how glycolysis affects cell survival, but one area of research is the glucose transporter family, especially GLUT1, said Dr. Rathmell. Cells need GLUT1 to proliferate normally. GLUT1 is rapidly induced and requires activation of the PI3-kinase pathway. It promotes human T cell growth and proliferation, and CD4 T cells will go on to differentiate into metabolically distinct effector or regulatory subsets that play a role in the inflammatory response.1 Each subset has different characteristics, and glycolysis is highest in Th1 and Th17.

T-regulatory and T-effector cells rely on distinct metabolic mechanisms, and Glut1 plays an important role in these processes, he said. Induced T-effector, but not T-regulatory, cells are affected by a deficiency of Glut1. T cells require Glut1 for the production and expansion of inflammatory cytokines in inflammatory bowel disease, for example.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Meeting Reports, Systemic Inflammatory Syndromes Tagged With: 2015 ACR/ARHP Annual Meeting, American College of Rheumatology, inflammation, inflammatory, metabolic, pathways, Research, Rheumatic Disease, rheumatology, signalingIssue: February 2016

You Might Also Like:
  • 2015 ACR/ARHP Annual Meeting: How to Identify, Manage Metabolic Myopathies & Their Mimics
  • 2015 ACR/ARHP Annual Meeting: Genetically Complex Auto-Inflammatory Diseases
  • 2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response
  • 2015 ACR/ARHP Annual Meeting: Macrophage Polarization and Its Role in Inflammatory Disease

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)